Poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as innate immune system activators

Area of Science:

• Immunology
• Nanotechnology
• Biomaterials

Background:

• Adjuvant research focuses on Toll-like receptor (TLR) agonists, with complement activation being less explored.
• Previous studies showed poly(methyl vinyl ether-co-maleic anhydride) nanoparticles (PVMA NPs) activate dendritic cells via TLR stimulation, but required high doses.
• A dose-response effect was observed, with lower PVMA NP concentrations stimulating TLR2 and TLR4.

Purpose of the Study:

• To investigate the dose-response of PVMA NPs on TLR stimulation.
• To explore the potential of PVMA NPs to activate the complement system for immunomodulatory benefits.
• To elucidate the mechanism of complement activation by PVMA NPs.

Main Methods:

• Dose-response studies on TLR2 and TLR4 transfected dendritic cells.
• Complement activation assays including adsorption studies and complement fixation bioassays.
• Analysis of C3b binding stability and complement consumption.
• Comparison with poly(lactic-co-glycolic acid) (PLGA) nanoparticles.
• Inhibition studies using cross-linked PVMA NPs.

Main Results:

• PVMA NPs stimulate TLR2 and TLR4 at concentrations as low as 20μg/mL.
• The hydroxylated surface of PVMA NPs strongly activates the complement cascade, leading to complement consumption.
• Stable C3b binding to PVMA NPs was confirmed.
• Minimal inhibitory concentration for complement consumption by PVMA NPs was 50μg (1cm²).
• PLGA nanoparticles did not consume complement at concentrations up to 3mg (40cm²).
• Cross-linking PVMA NPs inhibited complement consumption, highlighting the role of hydroxyl groups.

Conclusions:

• PVMA NPs act as effective adjuvants by stimulating both TLRs and the complement system.
• The hydroxyl groups on PVMA NPs are crucial for complement activation.
• PVMA NPs likely attract immature antigen-presenting cells via complement activation, followed by TLR2 and TLR4-mediated activation.